Co-Authors
This is a "connection" page, showing publications co-authored by Elizabeth Graef and Alfred Kim.
Connection Strength
1.453
-
Inflammatory arthritis in patients with COVID-19. Transl Res. 2021 06; 232:49-59.
Score: 0.233
-
Reply to 'Taking a stand against the politicization of medical research: how "swinging the pendulum" poses a hazard to clinical trials, study participants, and the progress of science'. Expert Rev Clin Immunol. 2021 01; 17(1):105-107.
Score: 0.230
-
Response to: 'Case series of acute arthritis in COVID-19 admission' by López-González et al. Ann Rheum Dis. 2020 May 29.
Score: 0.221
-
Response to: 'Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?' by Erre et al. Ann Rheum Dis. 2020 May 18.
Score: 0.221
-
Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist. Ann Rheum Dis. 2020 06; 79(6):734-736.
Score: 0.219
-
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med. 2020 06 16; 172(12):819-821.
Score: 0.219
-
Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Rev Clin Immunol. 2020 07; 16(7):659-666.
Score: 0.056
-
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. Ann Rheum Dis. 2020 10; 79(10):1386-1388.
Score: 0.055